logo
ResearchBunny Logo
speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing

Medicine and Health

speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing

R. Castellanos-rueda, R. B. D. Roberto, et al.

This groundbreaking research by Rocío Castellanos-Rueda, Raphaël B. Di Roberto, and others showcases speedingCARs, a novel method that utilizes engineered chimeric antigen receptors for enhanced T cell responses against tumors. By integrating a diverse library of CAR variants into human T cells, the study identifies potentiated tumor-killing properties through advanced sequencing techniques, paving the way for innovative cancer therapies.

00:00
00:00
~3 min • Beginner • English
Abstract
Chimeric antigen receptors (CARs) consist of an antigen-binding region fused to intracellular signaling domains, enabling customized T cell responses against targets. Despite their major role in T cell activation, effector function and persistence, only a small set of immune signaling domains have been explored. Here we present speedingCARs, an integrated method for engineering CAR T cells via signaling domain shuffling and pooled functional screening. Leveraging the inherent modularity of natural signaling domains, we generate a library of 180 unique CAR variants genomically integrated into primary human T cells by CRISPR-Cas9. In vitro tumor cell co-culture, followed by single-cell RNA sequencing (scRNA-seq) and single-cell CAR sequencing (scCAR-seq), enables high-throughput screening for identifying several variants with tumor killing properties and T cell phenotypes markedly different from standard CARs. Mapping of the CAR scRNA-seq data onto that of tumor infiltrating lymphocytes further helps guide the selection of variants. These results thus help expand the CAR signaling domain combination space, and supports speedingCARs as a tool for the engineering of CARs for potential therapeutic development.
Publisher
Nature Communications
Published On
Nov 02, 2022
Authors
Rocío Castellanos-Rueda, Raphaël B. Di Roberto, Florian Bieberich, Fabrice S. Schlatter, Darya Palianina, Oanh T. P. Nguyen, Edo Kapetanovic, Heinz Läubli, Andreas Hierlemann, Nina Khanna, Sai T. Reddy
Tags
chimeric antigen receptors
CAR T cells
tumor-killing
CRISPR-Cas9
single-cell RNA sequencing
functional screening
T cell engineering
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny